Skip to main content
Log in

An Optoelectronic Spectral Sensor for Monitoring the Elimination of Uremic Markers with Low and Middle Molecular Weight during Hemodialysis Therapy

  • Published:
Biomedical Engineering Aims and scope

An optoelectronic spectral system was developed for monitoring the elimination of uremia markers of low and middle molecular weight during hemodialysis therapy by measuring UV absorption at 285 and 365 nm. The elimination kinetics of AGE products were analyzed using a two-pool model in comparison with the conventional markers for dialysis adequacy. These studies showed that monitoring of optical absorption at 365 nm could be used as an alternative method for assessing hemodialysis adequacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bikbov, B., et al., “Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study,” Lancet, 395, No. 10225, 709-733 (2017).

    Article  Google Scholar 

  2. Hörl, W. H., Koch, K.-M., Lindsay, R. M., Ronco C., and Winchesterm, J. F., Replacement of Renal Function by Dialysis, Springer, Netherlands (2004), pp. 73-95.

    Google Scholar 

  3. “KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update,” Am. J. Kidney Dis., 66, No. 5, 884-930 (2015).

  4. Daugirdas, J. T. and Tattersallm, J. E., “Automated monitoring of hemodialysis adequacy by dialysis machines: Potential benefits to patients and cost savings,” Kidney Int., 78, No. 9, 833-835 (2010).

    Article  Google Scholar 

  5. Keshaviah, P. R., Ebben, J. P., and Emersonm, P. F., “On-line monitoring of the delivery of the hemodialysis prescription,” Pediatr. Nephrol., 9, Supplement 1, S2 (1995).

  6. Aslam, S., Saggi, S. J., Salifu, M., and Kossmannm, R. J., “Online measurement of hemodialysis adequacy using effective ionic dialysance of sodium – A review of its principles, applications, benefits, and risks,” Hemodial. Int., 22, No. 4, 425-434 (2018).

    Article  Google Scholar 

  7. Castellarnau, A., Werner, M., Günthner, R., and Jakob, M., “Real-time Kt/V determination by ultraviolet absorbance in spent dialysate: Technique validation,” Kidney Int., 78, 920-925 (2010).

    Article  CAS  Google Scholar 

  8. Vasilevsky, A. M., et al., “Dual-wavelength optoelectronic sensor for monitoring uric acid concentration in dialysate,” Biomed. Eng., 49, 125-128 (2015).

    Article  Google Scholar 

  9. Konoplev, G. A., Stepanova, O. S., Zemchenkov, G. A., and Frorip, A., “Optical spectral sensor for the assessment of uric acid kinetics during hemodialysis treatment,” J. Phys. Conf. Ser., 1410 (2019).

  10. Lauri, K., et al., “Removal of urea, β2-microglobulin, and indoxyl sulfate assessed by absorbance and fluorescence in the spent dialysate during hemodialysis,” ASAIO J., 201966, No. 6, 698-705.

  11. Vanholder, R., Pletinck, A., Schepers, E., and Glorieux, G., “Biochemical and clinical impact of organic uremic retention solutes: A comprehensive update,” Toxins, 10, 33 (2018).

    Article  Google Scholar 

  12. Clark, W. R., Dehghani, N. L., Narsimhan, V., and Ronco, C., “Uremic toxins and their relation to dialysis efficacy,” Blood Purif., 48, 299-314 (2019).

    Article  CAS  Google Scholar 

  13. Davenport, A., “Moving beyond small solute clearance: What evidence is there for more permeable dialyzers and haemodiafiltration?” Hemodial. Int., 22, Supplement 2, S24-S28 (2018).

  14. Maheshwari, K. U., Santhi, S., and Malarm, R. J., and Cystatin, C., “An alternative dialysis adequacy marker in high flux hemodialysis,” Ind. J. Nephrol., 25, 143-145 (2015).

  15. Uhlin F., Holmar, J., Yngman-Uhlin, P., Fernstrцm, A., and Fridolin, I., “Optical estimation of beta 2 microglobulin during hemodiafiltration – does it work?” Blood Purif., 201540, No. 2, 113-119.

  16. Papanastasiou, P., et al., “Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD,” Kidney Int., 46, 216-222 (1994).

    Article  CAS  Google Scholar 

  17. Stinghen, A. E. M., Massy, Z. A., Vlassara, H., Striker, G. E., and Boullier, A., “Uremic toxicity of advanced glycation end products in CKD,” J. Am. Soc. Nephrol., 27, No. 2, 354-370 (2016).

    Article  CAS  Google Scholar 

  18. Jiang J., Zhang Y., and Chen, J., et al., “Serum and tissue levels of advanced glycation end products and risk of mortality in patients on maintenance hemodialysis,” American J. Nephrol., 52, No. 1, 8-16 (2021).

  19. Kuznetsov, A., et al., “Multimode monitoring of AGE excretion in hemodialysis,” Nephrol. Dial. Transplant., 1, Supplement 1, 1500-1501 (2016).

  20. Fridolin, I., Karai D., Kostin, S., and Ubar, R., “Accurate dialysis dose evaluation and extrapolation algorithms during online optical dialysis monitoring,” IEEE Trans. Biomed. Eng., 60, 1371-1377 (2012).

    Article  Google Scholar 

  21. Uhlin F., Fridolin, I., Magnusson, M., and Lindberg, L.-G., “Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance,” Nephrol. Dial. Transplant., 21, No. 8, 2225-2231 (2006).

    Article  CAS  Google Scholar 

  22. Schneditz, D., Fariyike, B., Osheroff, R., and Levinm, N. W., “Is intercompartmental urea clearance during hemodialysis a perfusion term? A comparison of two pool urea kinetic models,” J. Am. Soc. Nephrol., 6, No. 5, 1360-1370 (1995).

    Article  CAS  Google Scholar 

  23. Burgelman, M., Vanholder, R., Fostier, H., and Ringoir, S., “Estimation of parameters in a two-pool urea kinetic model for hemodialysis,” Med. Eng. Phys., 19, No. 1, 69-76 (1997).

    Article  CAS  Google Scholar 

  24. Vasilevsky, A. M., Konoplev, G. A., Stepanova, O. S., Zemchenkov, A. Y., Gerasimchuk, R. P., and Frorip, A., “Dual-wavelength method and optoelectronic sensor for online monitoring of the efficiency of dialysis treatment,” J. Phys. Conf. Ser., 643 (2015).

  25. Kuznetsov, A., Frorip, A., Maiste, A., Ots-Rosenberg, M., Sünter, A., Sablonin, J., and Vasil’chenko, J., “Advanced glycation end products in hemodialysates as fluorescent and optical absorption markers of patients mortality,” in: 8th Int. Conf. on Advanced Optical Materials and Devices (AOMD-8), Vol. 9421 (2014).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. S. Stepanova.

Additional information

Translated from Meditsinskaya Tekhnika, Vol. 56, No. 1, Jan.-Feb., 2022, pp. 13-17.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zemchenkov, G.A., Konoplev, G.A., Korsakov, V. et al. An Optoelectronic Spectral Sensor for Monitoring the Elimination of Uremic Markers with Low and Middle Molecular Weight during Hemodialysis Therapy. Biomed Eng 56, 18–23 (2022). https://doi.org/10.1007/s10527-022-10158-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10527-022-10158-7

Navigation